Acute lymphocytic leukemia: Difference between revisions

No edit summary
 
Line 7: Line 7:
==Clinical Features==
==Clinical Features==
*[[leukocytosis|Lymphocytosis]], [[neutropenia]], [[anemia]], [[thrombocytopenia]]  
*[[leukocytosis|Lymphocytosis]], [[neutropenia]], [[anemia]], [[thrombocytopenia]]  
*[[Lymphadenopathy]], [[hepatosplenomegaly]]  
*[[Lymphadenopathy]], [[hepatomegaly|hepatosplenomegaly]]  
*CNS and testes involvement common
*CNS and testes involvement common
*Symptomatic [[leukostasis and hyperleukocytosis]] are more common in AML than in ALL, CML, CLL<ref>Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a
*Symptomatic [[leukostasis and hyperleukocytosis]] are more common in AML than in ALL, CML, CLL<ref>Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a

Latest revision as of 23:21, 30 September 2019

Background

  • Characterized by proliferation of immature lymphoblast( >20% in periphery)
  • Less than 20% of acute leukemias in adults,
  • Most common form in children (see also Leukemia (Peds))
  • Highest incidence in 7th decade of life

Clinical Features

Differential Diagnosis

Acute Leukemia/Lymphoma

Evaluation

  • CXR
  • CBC with peripheral smear
  • Chem7, Ca, Mg, Phos, Uric Acid, UA, LDH (to check for tumor lysis syndrome)
  • LFTs, Coags, FDP, D-Dimer, Haptoglobin, Fibrinogen (to check for DIC)
  • ESR, CRP
  • Reticulocyte count in anemia
  • Get extra purple top for flow cytometry, especially before transfusion

Management

See Also

References

  1. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk.Lymphoma. 2000;39(1-2):1-18.